Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 10/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | FSHR | P23945 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22756470 | 0.83 | HDAC1 (0.36) | RXRAHDAC1HDAC6 | |
| SCHEMBL20616484 | 0.83 | PGR (0.45) | RXRAFSHRBRD4NR3C2PGR | |
| SCHEMBL20344739 | 0.81 | BRD4 (0.42) | HDAC1HDAC6BRD4KDM4EALDH1A1 | |
| SCHEMBL29424983 | 0.81 | BRD4 (0.42) | HDAC1HDAC6BRD4KDM4EALDH1A1 | |
| SCHEMBL20344736 | 0.81 | RXRA (0.35) | RXRAHDAC1HDAC6 | |
| SCHEMBL20616459 | 0.80 | BRD4 (0.37) | RXRAFSHRBRD4KDM4EALDH1A1 | |
| SCHEMBL20344793 | 0.79 | BRD4 (0.32) | RXRABRD4KDM4EALDH1A1HPGD | |
| SCHEMBL20616468 | 0.77 | BRD4 (0.40) | RXRABRD4KDM4EALDH1A1HPGD | |
| SCHEMBL20616471 | 0.76 | BRD4 (0.37) | BRD4KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL20616464 | 0.76 | BRD4 (0.37) | BRD4KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3342766-B1 | SMALL MOLECULE COMPOUND FOR ENHANCING PLANT STRESS RESISTANCE | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2020-12-09 | — | — | EP | disclosed |
| US-10842151-B2 | Small molecule compound for enhancing plant stress resistance | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2020-11-24 | — | — | US | disclosed |
| EP-3342766-A1 | SMALL MOLECULE COMPOUND FOR ENHANCING PLANT STRESS RESISTANCE | Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (CN) | 2018-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10842151-B2 | Small molecule compound for enhancing plant stress resistance | CYP4F11, RICTOR, MYB | RXRA 1372/4885HDAC1 1165/4885HDAC6 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.